Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection

NCT03050307 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Ulcer

Interventions

DRUG: TAK-438
DRUG: Lansoprazole
DRUG: TAK-438 Placebo
DRUG: Lansoprazole Placebo
DRUG: Bismuth-Containing Quadruple Therapy

Sponsor

Takeda